116 related articles for article (PubMed ID: 15236794)
1. Brain cholinesterases: III. Future perspectives of AD research and clinical practice.
Shen ZX
Med Hypotheses; 2004; 63(2):298-307. PubMed ID: 15236794
[TBL] [Abstract][Full Text] [Related]
2. Brain cholinesterases: I. The clinico-histopathological and biochemical basis of Alzheimer's disease.
Shen ZX
Med Hypotheses; 2004; 63(2):285-97. PubMed ID: 15236793
[TBL] [Abstract][Full Text] [Related]
3. Brain cholinesterases: II. The molecular and cellular basis of Alzheimer's disease.
Shen ZX
Med Hypotheses; 2004; 63(2):308-21. PubMed ID: 15236795
[TBL] [Abstract][Full Text] [Related]
4. Rationale for diagnosing deficiency of ChEs and for applying exogenous HuChEs to the treatment of diseases.
Shen ZX
Med Hypotheses; 2008; 70(1):43-51. PubMed ID: 17587508
[TBL] [Abstract][Full Text] [Related]
5. Expression of cholinesterases in brain and non-brain tumours.
Vidal CJ
Chem Biol Interact; 2005 Dec; 157-158():227-32. PubMed ID: 16256970
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease therapy - an update.
Nikolov R
Drug News Perspect; 1998 May; 11(4):248-55. PubMed ID: 15616667
[TBL] [Abstract][Full Text] [Related]
7. Cholinesterases (ChEs) and the cholinergic system in ontogenesis and phylogenesis, and non-classical roles of cholinesterases - a review.
Karczmar AG
Chem Biol Interact; 2010 Sep; 187(1-3):34-43. PubMed ID: 20226178
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
9. Cholinesterases and the pathology of Alzheimer disease.
Geula C; Mesulam MM
Alzheimer Dis Assoc Disord; 1995; 9 Suppl 2():23-8. PubMed ID: 8534419
[TBL] [Abstract][Full Text] [Related]
10. High aryl acylamidase activity associated with cobra venom acetylcholinesterase: biological significance.
Rajesh RV; Layer PG; Boopathy R
Biochimie; 2009; 91(11-12):1450-6. PubMed ID: 19695303
[TBL] [Abstract][Full Text] [Related]
11. Citicoline: pharmacological and clinical review, 2006 update.
Secades JJ; Lorenzo JL
Methods Find Exp Clin Pharmacol; 2006 Sep; 28 Suppl B():1-56. PubMed ID: 17171187
[TBL] [Abstract][Full Text] [Related]
12. Bioscavengers for the protection of humans against organophosphate toxicity.
Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
14. Cholinesterases in development and disease.
Anglister L; Etlin A; Finkel E; Durrant AR; Lev-Tov A
Chem Biol Interact; 2008 Sep; 175(1-3):92-100. PubMed ID: 18571632
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cholinesterases in marbled sole, Limanda yokohamae, and their inhibition in vitro by the fungicide iprobenfos.
Jung JH; Addison RF; Shim WJ
Mar Environ Res; 2007 Jun; 63(5):471-8. PubMed ID: 17300836
[TBL] [Abstract][Full Text] [Related]
16. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.
Conant R; Schauss AG
Altern Med Rev; 2004 Mar; 9(1):17-31. PubMed ID: 15005642
[TBL] [Abstract][Full Text] [Related]
19. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
da Silva CH; Campo VL; Carvalho I; Taft CA
J Mol Graph Model; 2006 Oct; 25(2):169-75. PubMed ID: 16413803
[TBL] [Abstract][Full Text] [Related]
20. [Physiological functions of carnitine and carnitine transporters in the central nervous system].
Inazu M; Matsumiya T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Jun; 28(3):113-20. PubMed ID: 18646596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
